Karista

Karista is an early-stage venture capital firm created in 2001. We funded 90+ companies over the past two decades and support tomorrow’s game changers in the field of Health, Digital, Tech, and NewSpace. We have always worked to provide more than cash and partnered with entrepreneurs whom we share a common vision with.

Tom Beauvironnet

Investment Manager

Catherine Boule

Managing Partner

Emmanuel Daugeras

Investment Director

Olivier Dubuisson

Managing Partner

Yvan-Michel Ehkirch

Managing Partner

Baudouin Hue

Partner

Michael Thomas

Senior Investment Manager

Benjamin Zerbib

Investment Director

149 past transactions

Aterovax

Seed Round in 2013
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

Exotrail

Series B in 2023
Exotrail SA develops electric propulsion systems and flight software for small satellites and constellations. Its product includes ExoMS, a propulsion system that facilitates constellations of small satellites to access new orbits; and ExoOPS, a cloud-based software that helps engineers to design and plan the operations of satellite missions. The company develops electric thrusters for nano and micro-satellites with applications in telecommunication, earth observation, and space and science. The company was founded in 2015 and is based in Palaiseau, France.

Green Point SAS

Seed Round in 2012
GreenPoint specialises in regtech, namely in digital and mobile management of know your customer (KYC), digital processing of customers’ records and customer on-boarding.

Tricares

Seed Round in 2015
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

VitamFero

Series C in 2015
VitamFero SA, a biotechnology company, designs, develops, registers, and markets prophylactic agents such as vaccines and neonatal immunostimulants for the treatment of various infectious diseases using Toxo Mic1-3KO. It offers vaccines, such as VFOtx-251, VFOne-273 and VFOlh-211 for the treatment of ovine toxoplasmosis, bovine neosporosis, canine leishmaniasis, and equine protozoal myeloencephalitis (EPM) respectively. The company was founded in 2005 and is based in Angers, France.

UpFactor

Seed Round in 2019
UpFactor offers site analysis services. Its geographic information system uses a database aggregating all of the information necessary for defining building potentials: addresses, street widths, building heights, PLU, solar land register, and protected areas. The company was founded in 2017 and is based in Paris, France.

Voluntis

Seed Round in 2006
Voluntis, Inc. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas. It offers Insulia, a prescription-only medical device that provides type 2 diabetes patients with insulin dose recommendations and educational coaching messages based on blood glucose values and other diabetes-related data; and Diabeo, a digital solution for type 1 and type 2 patients treated on a basal-bolus insulin regimen, which suggests insulin dosage, through algorithmic calculations that are specific to the patient and based on their particular doses. Voluntis, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.

Restlet

Convertible Note in 2016
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Admo.tv

Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Aterovax

Seed Round in 2015
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

Nanobiotix

Series C in 2010
Nanobiotix SA operates as a clinical-stage nanomedicine company for the treatment of cancer worldwide. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a radio-enhancer hafnium oxide for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, and other cancers. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France.

Rool'in

Seed Round in 2014
Rool'in offers innovative, practical and ecological solutions in the field of bicycle mobility.

Open Ocean

Seed Round in 2015
Open Ocean is an innovative company based in Brest and Paris, which conceives since 2011 online decision-making solutions for industrial marine activities. Their highly qualified team of oceanographers, trained in the best research oceanographic institutes of the world (UPMC, IFREMER, University of Washington) is specialized in high resolution modelling, statistical analysis and data mining.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA engages in the research and development of lytic bacteriophages for therapeutic and diagnostic applications with a focus on antibiotic resistance. It develops several banks of bacteriophages, including the collection of phages against Escherichia coli. The company was incorporated in 2006 and is based in Romainville, France.

Bnbsitter

Series A in 2016
Bnbsitter allows vacation rental hosts to book welcome services for their guests. Guests’ check-in/check-out and rental cleaning are booked in less than two minutes. Busy at work, away for vacations or unable to meet arriving guests, Bnbsitter helps hosts to greet and welcome their guests with a smile!

Kranus Health

Series A in 2022
Kranus Health is a global provider for Men‘s Health Digital Therapeutics. Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

Prestodiag

Series A in 2015
Prestodiag develops, manufactures and sells innovative solutions for rapid detection of bacteria. Their analytical solutions are based on an innovative optics technology called Surface Plasmon Resonance imaging and allow detection and identification of pathogenic bacteria such as Salmonella, Listeria or E.coli. They provide users with a result in just a few hours instead of 1 to several days. Their market is primarily the food safety sector, and also on medical and environmental applications.

Plasmabiotics

Seed Round in 2012
SAS PlasmaBiotics operates as a biotechnology company that designs, manufactures and markets generators of cold plasma nitrogen for medical disinfection. The company was incorporated in 2011 and is based in Evry, France. As of August 1, 2018, SAS PlasmaBiotics operates as a subsidiary of HOYA Corporation.

OpenOcean

Seed Round in 2015
OpenOcean is an early-stage venture capital firm investing across Europe with offices in London, Helsinki, and Amsterdam. With an entrepreneurial background from building several category-defining software businesses, the firm engages with founders to build and scale global companies delivering data-intensive and delicious software solutions. OpenOcean typically leads or co-leads €5M Series A funding rounds in Europe.

DBV Technologies

Seed Round in 2006
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.

Codasystem

Venture Round in 2005
Codasystem is a French start-up which offers a real time monitoring tool, using software that allows users to take digital photographs with a mobile telephone that can be used as legal proof.

Xcalia

Series B in 2004
Xcalia provides intermediation software to create dynamic transactional composite applications. The Xcalia Intermediation Platformâ„¢ combines legacy, mainframe and database resources with web services to dynamically integrate and orchestrate application business processes. As a critical requirement for implementing SOA, it uses metadata to describe services and automatically executes transactions at runtime. Xcalia allows enterprises to quickly respond to changing business requirements and eliminates the need for costly manual integration. Xcalia, founded in 2000, is powering high-volume transactional environments in over 50 companies. Headquartered in Paris, France, it has offices in the US, UK, and Germany.

Sequans Communications

Series C in 2006
Sequans Communications S.A. (NYSE: SQNS) is a 4G chipmaker and leading provider of single-mode LTE chipset solutions to wireless device manufacturers worldwide. Founded in 2003, Sequans has developed and delivered seven generations of 4G technology and its chips are certified and shipping in 4G networks around the world. Today, Sequans offers two LTE product lines: StreamrichLTE™, optimized for feature-rich mobile computing and home/portable router devices, and StreamliteLTE™, optimized for M2M devices and other connected devices for the Internet of Things. Sequans is based in Paris, France with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

AlephD

Series A in 2013
AlephD SAS provides publishers with real-time optimization strategies together with business intelligence solutions. It offers YieldEngine, a real-time yield management solution for AppNexus; InstantPredict, which addresses publishers’ constant need to decide what source of revenue to prioritize; and InventoryLab, an integrated software suite to help publishers to make decisions based on data analysis and business intelligence tools. The company was incorporated in 2012 and is based in Paris, France. As of January 25, 2016, AlephD SAS operates as a subsidiary of AOL Inc.

Xcalia

Series A in 2003
Xcalia provides intermediation software to create dynamic transactional composite applications. The Xcalia Intermediation Platformâ„¢ combines legacy, mainframe and database resources with web services to dynamically integrate and orchestrate application business processes. As a critical requirement for implementing SOA, it uses metadata to describe services and automatically executes transactions at runtime. Xcalia allows enterprises to quickly respond to changing business requirements and eliminates the need for costly manual integration. Xcalia, founded in 2000, is powering high-volume transactional environments in over 50 companies. Headquartered in Paris, France, it has offices in the US, UK, and Germany.

Kynogon

Seed Round in 2003
Kynogon SA develops and markets artificial intelligence software for interactive applications. It provides its services to various industries, including gaming, defense and security, industrial, simulation, and education. Kynogon SA was founded in 2000 and is based in Suresnes, France with additional offices in Canada and the United Kingdom. As of May 7, 2008, Kynogon SA operates as a subsidiary of Autodesk, Inc.

Idylis

Series A in 2005
Idylis S.A. designs, develops, and markets software solutions for enterprise management. Its products assist in audit and accounting, financial management, documentation, e-mailing, and scheduling applications. The company also offers solutions for commercial applications such as supply chain management, logistics, and inventory management. In addition, it provides customer support and consulting services to its clients. The company was incorporated in 2008 and is based in Issy-les-Moulineaux, France.

Nanoe

Seed Round in 2013
Nanoe Sarl develops ready-to-sinter nanopowders for the ceramic industry. It offers ready-to-press granulates, slurries, raw materials, and tailor-made solutions. The company was founded in 2008 and is based in Chilly-Mazarin, France.

Implicity

Seed Round in 2019
Implicity is a developer of a Saas based remote monitoring plaform designed to provide smart monitoring of connected cardiac prostheses. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of artificial intelligence module and determines the criticality of each alert taking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform.

Echosens

Acquisition in 2004
Echosens SAS develops, manufactures, and markets non-invasive diagnostic products and services for hepatology. It offers FibroScan, a vibration controlled transient elastography technology and is used in routine clinical practice and research; FibroMeter that provides blood tests to quantify the presence of fibrosis in the liver; and FibroView, a smart connectivity software solutions linking FibroScan to the hospital information systems. The company was incorporated in 2001 and is based in Paris, France.

Advestigo

Series B in 2008
Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package that allows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.

Linkfluence

Series C in 2016
Social Media Intelligence

Restlet

Convertible Note in 2014
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Restlet

Seed Round in 2013
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Incepto Medical

Seed Round in 2019
Incepto Medical SAS develops and distributes artificial intelligence (AI) applications for medical imaging. The company’s products include Qure.ai qER, a software to help physicians in reading head CTs; Qure.ai qXR, a software to detect thorax abnormalities; Aidence Veye Chest for detecting, classifying, and tracking pulmonary nodules growth; Icometric Icobrain to monitor neurological disorders; and ScreenPoint Transpara to detect breast cancer. It also owns and operates Collective Minds Radiology, an online platform to get support on cases, share opinions, and learn from others. The company was founded in 2018 and is based in Paris, France.

NAVYA

Venture Round in 2016
Navya SA, through its subsidiaries, provides full self-driving technology and vehicles primarily in the United States, and the EMEA and Asia-Pacific regions. It creates, develops, produces, and services autonomous, driverless, shared, and electric mobility solutions, such as autonomous shuttles and the autonomous cabs. The company offers its products primarily to municipalities, companies, industrial sites, theme parks, universities, and airports. Navya SA was founded in 2014 and is headquartered in Villeurbanne, France.

Oralance Pharma

Seed Round in 2004
Oralance is a developer of a new oral drug delivery system. Its technology is applied to a wide range of pharmaceuticals in the form of syrups, tablets, powder to dilute, lyophilic, gel, paste forms, and aqueous suspensions and is based on an original galenic micro-encapsulation process.

DBV Technologies

Acquisition in 2003
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.

e(ye)BRAIN

Series A in 2009
e(ye)BRAIN is a medical company that manufactures and distributes eye trackers for its clients. e(ye)BRAIN’s range of products include Eye Brain T1 and T2. The T1 enables its users to record eye movements. T2 uses algorithms to enable its users to record eye and head movements. The recorded movements will be analyzed by a software called MeyeEval. The company offers advisory, paradigm development, formation, and support services to its clients. e(ye)BRAIN was founded in 2008 by Serge Kinkingnehun and is based in France.

erytech

Seed Round in 2006
ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.

Comiteo

Venture Round in 2016
Comitéo, founded in 2008, designs and innovative services adapted to works councils. Comitéo supports a simple idea: to facilitate the mission of the elected by offering a web platform and mobile application, highly configurable for access to technology, culture, recreation, management and communication.

Nanobiotix

Seed Round in 2005
Nanobiotix SA operates as a clinical-stage nanomedicine company for the treatment of cancer worldwide. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a radio-enhancer hafnium oxide for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, and other cancers. Nanobiotix SA was incorporated in 2003 and is headquartered in Paris, France.

erytech

Series A in 2005
ERYtech Pharma, set up in Lyon (France) in 2004, specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.

Melusyn

Seed Round in 2016
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

InnaVirVax

Series A in 2009
InnaVirVax is a privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and new cancer therapies.

Plasmabiotics

Acquisition in 2012
SAS PlasmaBiotics operates as a biotechnology company that designs, manufactures and markets generators of cold plasma nitrogen for medical disinfection. The company was incorporated in 2011 and is based in Evry, France. As of August 1, 2018, SAS PlasmaBiotics operates as a subsidiary of HOYA Corporation.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS, a biotechnology company, develops therapeutic monoclonal antibodies for the treatment of acute thrombotic diseases. It engages in developing Glenzocimab, a humanized antibody for the treatment of cerebral stroke and the platelet glycoprotein VI. The company was founded in 2013 and is headquartered in Paris, France.

Stootie

Seed Round in 2015
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.

Sequans Communications

Series A in 2004
Sequans Communications S.A. (NYSE: SQNS) is a 4G chipmaker and leading provider of single-mode LTE chipset solutions to wireless device manufacturers worldwide. Founded in 2003, Sequans has developed and delivered seven generations of 4G technology and its chips are certified and shipping in 4G networks around the world. Today, Sequans offers two LTE product lines: StreamrichLTE™, optimized for feature-rich mobile computing and home/portable router devices, and StreamliteLTE™, optimized for M2M devices and other connected devices for the Internet of Things. Sequans is based in Paris, France with additional offices in the United States, United Kingdom, Israel, Hong Kong, Singapore, Taiwan, South Korea, and China.

Voluntis

Venture Round in 2007
Voluntis, Inc. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas. It offers Insulia, a prescription-only medical device that provides type 2 diabetes patients with insulin dose recommendations and educational coaching messages based on blood glucose values and other diabetes-related data; and Diabeo, a digital solution for type 1 and type 2 patients treated on a basal-bolus insulin regimen, which suggests insulin dosage, through algorithmic calculations that are specific to the patient and based on their particular doses. Voluntis, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.

Fidzup

Angel Round in 2013
Fidzup provides web oriented tools to brick & mortar businesses. The company has created a unique instore analytics platform that allows retailers to retarget their customers with personalized ads on mobile. The company was incorporated in 2013 and is based in Paris, France.

Acticor Biotech

Series A in 2018
Acticor Biotech SAS, a biotechnology company, develops therapeutic monoclonal antibodies for the treatment of acute thrombotic diseases. It engages in developing Glenzocimab, a humanized antibody for the treatment of cerebral stroke and the platelet glycoprotein VI. The company was founded in 2013 and is headquartered in Paris, France.

Sesamea

Series A in 2008
Sesamea is a French company providing electronic gift and cash cards, redeemable at a number of stores and french retailers.

actvt

Seed Round in 2015
Actvt Inc. aims to break the barriers to social video through cutting edge video editing technology. We turn long videos into short-form content that's actually fun to watch and share. Product portfolio: * Activity: An assisted video editing and social networking app that lets users effortlessly select highlights from their footage and automatically generate short edits on-the-go. Available on iOS and Android. * Showdown.cc: An in-game replay plugin for game developers that allows players to create, share, and discover gameplay videos.

Nokad

Seed Round in 2005
Nokad is a biotechnology company that focuses on the discovery and development of new diagnostic strategies for cardiovascular diseases. The company develops an innovative knowledge of the regulatory mechanisms involved in hyperactive platelet production both in human and in experimental models.

Nexdot

Venture Round in 2016
Nexdot SAS develops, manufactures, and applies semiconductor nanocrystals of controlled size and shape called Quantum Dots. The company was incorporated in 2016 and is based in Romainville, France.

English Attack

Series A in 2015
Entertainment Learning SAS operates English Attack, an online English language learning platform for independent teachers, schools, universities, language institutes, and companies in Greece and Cyprus. It offers video exercises based on movies, TV series, music, and current events; visual dictionaries on various topics; a range of language games that allow users to review vocabulary items, practice irregular verbs, and fine-tune oral comprehension; and private English lessons. The company offers its service as a subscription service direct to consumers; via multi-user licenses to schools, language institutes, universities, and other educational institutions; and company language training programs. Entertainment Learning SAS was founded in 2009 and is based in Paris, France.

Exotrail

Series A in 2020
Exotrail SA develops electric propulsion systems and flight software for small satellites and constellations. Its product includes ExoMS, a propulsion system that facilitates constellations of small satellites to access new orbits; and ExoOPS, a cloud-based software that helps engineers to design and plan the operations of satellite missions. The company develops electric thrusters for nano and micro-satellites with applications in telecommunication, earth observation, and space and science. The company was founded in 2015 and is based in Palaiseau, France.

Kranus Health

Series A in 2023
Kranus Health is a global provider for Men‘s Health Digital Therapeutics. Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

Beev

Seed Round in 2023
Electric cars for everyone

Exotrail

Series B in 2023
Exotrail SA develops electric propulsion systems and flight software for small satellites and constellations. Its product includes ExoMS, a propulsion system that facilitates constellations of small satellites to access new orbits; and ExoOPS, a cloud-based software that helps engineers to design and plan the operations of satellite missions. The company develops electric thrusters for nano and micro-satellites with applications in telecommunication, earth observation, and space and science. The company was founded in 2015 and is based in Palaiseau, France.

CYSEC

Seed Round in 2022
CYSEC is a startup working on next generation Confidential Computing solutions securing data at rest, in motion and in use. Currently they have released their ARCA solution which is quickly becoming one of the more popular choices in the market.

Tricares

Series C in 2022
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Incepto Medical

Venture Round in 2022
Incepto Medical SAS develops and distributes artificial intelligence (AI) applications for medical imaging. The company’s products include Qure.ai qER, a software to help physicians in reading head CTs; Qure.ai qXR, a software to detect thorax abnormalities; Aidence Veye Chest for detecting, classifying, and tracking pulmonary nodules growth; Icometric Icobrain to monitor neurological disorders; and ScreenPoint Transpara to detect breast cancer. It also owns and operates Collective Minds Radiology, an online platform to get support on cases, share opinions, and learn from others. The company was founded in 2018 and is based in Paris, France.

Deemea

Seed Round in 2024
Deemea is a collaborative AI platform that connects and provides services for the analysis of medical data for physicians. It uses its expertise in clinical research, data science, and software development to help healthcare professionals.

MOPeasy

Venture Round in 2015
MOPeasy, ecomobility operator, provides solutions for car sharing of electric vehicules and others, car pooling and access and reservations for charging stations, all in one platform. THE community solution adapted to companies, cities and collective habitats. MOPeasy turns charging stations into mobility stations, operates from 1 to 50 vehicules fleet for a Company. and from 1 station in Rural Communities up to 100 stations across a territory. Interoperable, MOPeasy's platform brings ecomobility solutions for Smart cities.

moveUP

Seed Round in 2021
moveUP develops and commercialise digital therapeutics solutions. Its closed loop system enables high compliance, better outcome and satisfaction. It uses continuously collected data to directly personalise the treatment of the patient. Its first therapy treats orthopaedic patients undergoing a joint surgery. It has CE medical device & ISO 13485 certification.

Acticor Biotech

Seed Round in 2017
Acticor Biotech SAS, a biotechnology company, develops therapeutic monoclonal antibodies for the treatment of acute thrombotic diseases. It engages in developing Glenzocimab, a humanized antibody for the treatment of cerebral stroke and the platelet glycoprotein VI. The company was founded in 2013 and is headquartered in Paris, France.

Stryng

Seed Round in 2012
​Stryng is an AI powered Client Messaging Platform.The company's platform combines live chat, audio and video communication, and live collaboration tools, and automatically classifies all messages by customers to keep track of all customer communication in one place, enabling mobile client-facing professionals to increase sales and deliver exceptional customer experience online.

Ludocare

Seed Round in 2022
Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

Theraclion

Acquisition in 2004
Theraclion Société anonyme develops, manufactures, and markets therapeutic ultrasound equipment. It offers an echotherapy solution that combines high-intensity focused ultrasound therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumours. The company also offers Echopulse for the non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules to practitioners; and SONOVEIN, an echotherapy solution using therapeutic ultrasound for the treatment of varicose veins. It operates in approximately 20 countries worldwide. The company was founded in 2004 and is based in Malakoff, France.

Neelogy

Seed Round in 2013
Neelogy develops and markets non-remanence magnetic sensors (thus very precise and non-intrusive) for the measurement of alternating and continuous electrical currents. The company's mission: to meet new needs related to energy metering, AC / DC energy conversion, electrical energy storage, real-time fault detection and diagnostics.

Mitricares

Seed Round in 2015
MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.

Sevenhugs

Seed Round in 2016
Sevenhugs Inc. develops ultra-wideband (UWB) systems for indoor positioning and orientation tracking. It offers software solution for smartphone, IoT device, and automotive manufacturers. The company offers smart remotes to control entertainment and smart home. It offers MAC protocol, ultra-low power consumption, small software footprint, sensor profiles, measurement, data fusion, and secure localization API features. The company offers access and security, spatial context, point and control, precision air mouse, location trackers, and data transfer features. Sevenhugs Inc. was founded in 2014 and is based in San Francisco, California. As of October 1, 2020, Sevenhugs Inc. operates as a subsidiary of Qorvo, Inc.

WeCook WeCare

Seed Round in 2012
WeCook is the new companion for a better nutrition and a better health. It uses his meal planner and the Alantaya's technology in order to offer the best high personnalized nutritionnal recommandation and the best coaching with dieteticians. High personnalized nutritionnal recommandation goes from Cancer to pregnancy.

Sitowie

Seed Round in 2022
Sitowie develops SaaS technology and tools to understand the degradation of buildings.

Tallano

Series A in 2019
Tallano Technologie manufactures particle collector that are present between the disc and the pad in private cars and public transport vehicles. The company offers tamic, a technology that traps the particles at source by suction. Tallano Technologie was incorporated in 2012 and is based in Boulogne-Billancourt, France.

Misakey

Seed Round in 2019
Misakey SAS designs and develops security software platform. The company offers an online platform that allows users to protect and manage their personal data across different social media platforms. It also enables webmasters to collaborate and integrate applications and create complaint websites. Misakey SAS was founded in 2018 and is based in Paris, France.

Implicity

Series A in 2022
Implicity is a developer of a Saas based remote monitoring plaform designed to provide smart monitoring of connected cardiac prostheses. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of artificial intelligence module and determines the criticality of each alert taking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform.

Stereolabs

Seed Round in 2013
Stereolabs builds technology that perceives and understand the world the way humans do. Stereolabs is the company behind Linq, the first mixed reality headset which lets you play games like never before in a world where the real and virtual merge seamlessly. The company also builds the ZED stereo camera, a camera coupled with powerful software that allows any object to perceive depth and motion just like humans do. The ZED has been adopted by thousands of developers worldwide and is increasingly used by major game makers to power mixed-reality capture of VR and AR games. For more information, please visit: www.linqmr.com and www.stereolabs.com

Humanlinker

Seed Round in 2022
Shaping the future of revenue generation. Humanlinker is a cutting-edge AI guided technology for revenue generation teams

Melusyn

Seed Round in 2015
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

Algaia

Seed Round in 2010
ALGAIA is a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed. ALGAIA offers a unique range of Natural and Sustainable products & solutions to the Agro-Nutrition, Personal Care and Pharmaceutical industries. Following the acquisition of Alganact SA, ALGAIA is also opening a Service Division for customers and partners willing to better understand the potential of their seaweed biomass or characterize their extracts.

Leanspace

Seed Round in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Acticor Biotech

Series B in 2018
Acticor Biotech SAS, a biotechnology company, develops therapeutic monoclonal antibodies for the treatment of acute thrombotic diseases. It engages in developing Glenzocimab, a humanized antibody for the treatment of cerebral stroke and the platelet glycoprotein VI. The company was founded in 2013 and is headquartered in Paris, France.

Playtem

Venture Round in 2014
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.

Eyevensys

Series B in 2020
Eyevensys S.A.S. develops non-viral gene therapy treatments for ophthalmology. The company’s develops Electro-Transfection (ET) of plasmids to the ciliary muscle therapy to deliver calibrated and sustained therapeutic proteins preferentially in the vitreous for several months. It develops an Electro-Transfection Injection System (ETIS) which is a drug device solution consisting of a device and a pulse generator. The company focuses on Uveitis, age-related macular degeneration (AMD), and retinopathies, including Central Retinal Vein Occlusion (RVO) and Diabetic Retinopathy (DR/DME). Eyevensys S.A.S. was incorporated in 2008 and is based in Paris, France.

Edenwall Technologies

Seed Round in 2010
Edenwall is a security vendor of identity-based firewall connection filtering solutions.

Serious Factory

Seed Round in 2015
Serious Factory is a publisher of innovative learning solutions for training purposes. Thanks to its expertise in instructional engineering and gamification, Serious Factory can help make your entire training programme genuinely effective: from acquiring knowledge (digital learning modules, Serious Games, blended learning and much more) and developing and strengthening skills (practical work, behavioural simulator, etc.) to updating content and monitoring skills from day to day.

Algaia

Acquisition in 2019
ALGAIA is a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed. ALGAIA offers a unique range of Natural and Sustainable products & solutions to the Agro-Nutrition, Personal Care and Pharmaceutical industries. Following the acquisition of Alganact SA, ALGAIA is also opening a Service Division for customers and partners willing to better understand the potential of their seaweed biomass or characterize their extracts.

Eyevensys

Seed Round in 2015
Eyevensys S.A.S. develops non-viral gene therapy treatments for ophthalmology. The company’s develops Electro-Transfection (ET) of plasmids to the ciliary muscle therapy to deliver calibrated and sustained therapeutic proteins preferentially in the vitreous for several months. It develops an Electro-Transfection Injection System (ETIS) which is a drug device solution consisting of a device and a pulse generator. The company focuses on Uveitis, age-related macular degeneration (AMD), and retinopathies, including Central Retinal Vein Occlusion (RVO) and Diabetic Retinopathy (DR/DME). Eyevensys S.A.S. was incorporated in 2008 and is based in Paris, France.

Physikron

Seed Round in 2010
Physikron is a developer of mass spectrometry technologies used to improve the performance of tandem spectrometry. Its technologies offer proteomic analysis and dramatically improves the number of peptides and proteins identified during an LC/MS/MS acquisition that enable researchers to research in an enhanced way.

Axess Vision Technology

Series B in 2013
Axess Vision Technology S.A. designs disposable sterile endoscopes. It offers bronchoscopy, urology, animal health, and other interface products. The company was founded in 2006 and is based in Saint-Pierre-des-Corps, France.